JP7374893B2 - ネコカリシウイルスワクチン - Google Patents

ネコカリシウイルスワクチン Download PDF

Info

Publication number
JP7374893B2
JP7374893B2 JP2020524368A JP2020524368A JP7374893B2 JP 7374893 B2 JP7374893 B2 JP 7374893B2 JP 2020524368 A JP2020524368 A JP 2020524368A JP 2020524368 A JP2020524368 A JP 2020524368A JP 7374893 B2 JP7374893 B2 JP 7374893B2
Authority
JP
Japan
Prior art keywords
fcv
vaccine
antigen
feline
rna replicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020524368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505529A (ja
Inventor
ターピー，イアン
Original Assignee
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2021505529A publication Critical patent/JP2021505529A/ja
Priority to JP2023135198A priority Critical patent/JP7721604B2/ja
Application granted granted Critical
Publication of JP7374893B2 publication Critical patent/JP7374893B2/ja
Priority to JP2025127770A priority patent/JP2025169275A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2020524368A 2017-12-08 2018-11-05 ネコカリシウイルスワクチン Active JP7374893B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023135198A JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン
JP2025127770A JP2025169275A (ja) 2017-12-08 2025-07-30 ネコカリシウイルスワクチン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762596508P 2017-12-08 2017-12-08
US62/596,508 2017-12-08
PCT/EP2018/080096 WO2019110213A1 (en) 2017-12-08 2018-11-05 Feline calicivirus vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023135198A Division JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン

Publications (2)

Publication Number Publication Date
JP2021505529A JP2021505529A (ja) 2021-02-18
JP7374893B2 true JP7374893B2 (ja) 2023-11-07

Family

ID=64316487

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020524368A Active JP7374893B2 (ja) 2017-12-08 2018-11-05 ネコカリシウイルスワクチン
JP2023135198A Active JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン
JP2025127770A Pending JP2025169275A (ja) 2017-12-08 2025-07-30 ネコカリシウイルスワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023135198A Active JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン
JP2025127770A Pending JP2025169275A (ja) 2017-12-08 2025-07-30 ネコカリシウイルスワクチン

Country Status (3)

Country Link
JP (3) JP7374893B2 (https=)
AU (2) AU2018380582B2 (https=)
WO (1) WO2019110213A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
WO2019115090A1 (en) * 2017-12-15 2019-06-20 Intervet International B.V. Multivalent feline vaccine
US11229699B2 (en) 2017-11-06 2022-01-25 Intervet Inc. Feline calicivirus vaccine
WO2021228731A1 (en) * 2020-05-11 2021-11-18 Intervet International B.V. Feline severe acute respiratory syndrome coronavirus 2 vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537761A (ja) 2004-05-18 2007-12-27 アルファバックス，インコーポレイティド Ｔｃ−８３由来アルファウイルスベクター、粒子および方法
WO2017109045A1 (en) 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527584A (ja) * 2000-03-09 2003-09-16 ヘスカ コーポレイション 動物の免疫状態を決定するための組換え抗原の使用
US7309495B2 (en) 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
DK2947149T3 (en) 2007-06-21 2018-06-06 Alphavax Inc ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537761A (ja) 2004-05-18 2007-12-27 アルファバックス，インコーポレイティド Ｔｃ−８３由来アルファウイルスベクター、粒子および方法
WO2017109045A1 (en) 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Expert Reviews in Molecular Medicine，2008年，10，e33

Also Published As

Publication number Publication date
JP2023159325A (ja) 2023-10-31
AU2018380582A1 (en) 2020-05-07
JP2025169275A (ja) 2025-11-12
JP7721604B2 (ja) 2025-08-12
WO2019110213A1 (en) 2019-06-13
JP2021505529A (ja) 2021-02-18
AU2018380582B2 (en) 2025-08-14
AU2025205386A1 (en) 2025-07-31

Similar Documents

Publication Publication Date Title
JP7721604B2 (ja) ネコカリシウイルスワクチン
JP7731670B2 (ja) ネコ白血病ウイルスワクチン
JP2024001076A (ja) 狂犬病ウイルスワクチン
JP2023179547A (ja) 多価ネコワクチン
US20240398934A1 (en) Feline leukemia virus vaccine
CN115697398A (zh) 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗
CN115768472A (zh) 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗
US11229699B2 (en) Feline calicivirus vaccine
CN115768785A (zh) 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗
RU2792898C2 (ru) Вакцина против кошачьего калицивируса
RU2797538C2 (ru) Поливалентная вакцина для животных семейства кошачьих
RU2782350C2 (ru) Вакцина против вируса бешенства
RU2784533C2 (ru) Вакцина против вируса лейкоза кошачьих
CN115836082A (zh) 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200702

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211011

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220819

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220823

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230823

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230829

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230926

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231025

R150 Certificate of patent or registration of utility model

Ref document number: 7374893

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150